CTLA4 and rheumatoid arthritis: In both the inflamed synovium and peripheral blood of RA patients, T cells with an activated phenotype were detected [27,28,29,30], these, in combination with the efficacy of co-stimulation blockade using CTLA-4 in therapy [31,32,33] support the importance of T cells as effector cells in RA.